Literature DB >> 9496240

Effects of cortisol on the expression of interleukin-6 and interleukin-1 beta in human osteoblast-like cells.

D Swolin-Eide1, C Ohlsson.   

Abstract

High levels of glucocorticoids are believed to alter bone remodeling by decreasing bone formation and increasing bone resorption. It has been suggested that different cytokines, like interleukin-6 (IL-6) and interleukin-1 (IL-1), are involved in bone resorption by activating immature osteoclasts, and some studies indicate that IL-6 promotes bone formation by a mitogenic effect on osteoblasts. The aim of the present investigation was to study whether cortisol regulates the expression of IL-6 and IL-1 beta in human osteoblast-like cells. A high dose of cortisol (10(-7)M) decreased, as expected, the C-terminal propeptide of type I collagen released into the culture medium. The IL-6 mRNA levels and IL-6 protein released into the culture medium were also decreased by cortisol in a dose-dependent manner. The maximum effect was seen at 1 microM cortisol (mRNA 23.1 +/- 7.9% of control culture; protein 28.2 +/- 8.3% of control culture). The decrease in IL-6 mRNA levels was apparent 4 h after the addition of cortisol and was still present 20 h later. The decrease in IL-6 protein released into the culture medium was seen 20 h later than the decrease in IL-6 mRNA levels. The production of IL-1 beta protein released into the culture medium was decreased in a dose-dependent manner after the addition of cortisol with a maximum effect at 1 microM. The effect of cortisol on IL-1 beta protein released into the culture medium was seen 16 h after the addition of cortisol. To summarize, cortisol decreases the expression of IL-6 as well as IL-1 beta in human osteoblast-like cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9496240     DOI: 10.1677/joe.0.1560107

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Intrapituitary cytokines in Cushing's disease: do they play a role?

Authors:  Agostino Paoletta; Giorgio Arnaldi; Roberta Papa; Marco Boscaro; Giacomo Tirabassi
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

2.  Posttraumatic stress disorder is associated with enhanced interleukin-6 response to mental stress in subjects with a recent myocardial infarction.

Authors:  Bruno B Lima; Muhammad Hammadah; Kobina Wilmot; Brad D Pearce; Amit Shah; Oleksiy Levantsevych; Belal Kaseer; Malik Obideen; Mohamad Mazen Gafeer; Jeong Hwan Kim; Samaah Sullivan; Tené T Lewis; Lei Weng; Lisa Elon; Lian Li; J Douglas Bremner; Paolo Raggi; Arshed Quyyumi; Viola Vaccarino
Journal:  Brain Behav Immun       Date:  2018-08-30       Impact factor: 7.217

3.  Acute Stress-Induced Changes in Follicular Dermal Papilla Cells and Mobilization of Mast Cells: Implications for Hair Growth.

Authors:  Hyoseung Shin; Soon-Jin Choi; A-Ri Cho; Dong Young Kim; Kyu Han Kim; Ohsang Kwon
Journal:  Ann Dermatol       Date:  2016-09-30       Impact factor: 1.444

4.  Acute murine antigen-induced arthritis is not affected by disruption of osteoblastic glucocorticoid signalling.

Authors:  Cornelia M Spies; Edgar Wiebe; Jinwen Tu; Aiqing Li; Timo Gaber; Dörte Huscher; Markus J Seibel; Hong Zhou; Frank Buttgereit
Journal:  BMC Musculoskelet Disord       Date:  2014-02-03       Impact factor: 2.362

5.  Addition of a dairy fraction rich in milk fat globule membrane to a high-saturated fat meal reduces the postprandial insulinaemic and inflammatory response in overweight and obese adults.

Authors:  Elieke Demmer; Marta D Van Loan; Nancy Rivera; Tara S Rogers; Erik R Gertz; J Bruce German; Jennifer T Smilowitz; Angela M Zivkovic
Journal:  J Nutr Sci       Date:  2016-03-07

6.  A Combination of Caffeine, TeaCrine® (Theacrine), and Dynamine® (Methylliberine) Increases Cognitive Performance and Reaction Time Without Interfering With Mood in Adult Male Egamers.

Authors:  Jaime L Tartar; Jonathan B Banks; Mykola Marang; Frankie Pizzo; Jose Antonio
Journal:  Cureus       Date:  2021-12-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.